#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatic angiosarcoma Infantile apnoea Ischaemic stroke Dupuytren's contracture Neutropenia Ewing's sarcoma recurrent Antiphospholipid antibodies Thalassaemia alpha Soft tissue sarcoma Sjogren's syndrome Albright's disease Uveitis Juvenile idiopathic arthritis Skin cancer Microscopic polyangiitis More trials…

    Learn about Rare Diseases

    Factor IX deficiency – Life with Disease Mucopolysaccharidosis II – Treatment Factor IX deficiency – Trials in Disease Lymphangioma – Diagnostics Osteosarcoma – Diagnostics Netherton’s syndrome – Basic Information Propionic acidaemia – Treatment Mucopolysaccharidosis – Treatment Mast cell activation syndrome – Life with Disease Sarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cldn6 Rna-Lpx Gozetotide Dextromethadone Hydrochloride Rly-4008 Dapirolizumab Pegol Colistin Sulfate Hydrocortisone Hemisuccinate Tryptophan LINAPRAZAN GLURATE Acetylcysteine Nirogacestat Hydrobromide LUXDEGALUTAMIDE AZD3632 Trastuzumab Doxecitine VGA039 Timothy Grass Pollen Extract Sodium Chloride Sertraline Regorafenib More therapies…

    Learn about Your Condition

    Metastasis Premature rupture of membranes Carotid arteriosclerosis Binge eating Hepatic neoplasm Benign prostatic hyperplasia Facial paresis Angina pectoris Pancreatic carcinoma stage IV Palpitations Menopause Hyperplasia adrenal Arteriovenous graft thrombosis Myelodysplastic syndrome Ocular melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Treatment of Severe Eye Chemical Burns with Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells for Patients with Severe Ocular Chemical Burns

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Povidone, Iodinated
    • Remifentanil Hydrochloride
    • Human Serum Albumin
    France

  • A study testing inhaled amikacin compared to placebo in critically ill patients with ventilator-associated tracheobronchitis

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Amikacin
    France

  • Testing inotuzumab ozogamicin and blinatumomab with drug combination for children with relapsed precursor B-cell acute lymphoblastic leukemia

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Prednisolone Sodium Succinate
    • Dexamethasone Phosphate
    • Vindesine Sulfate
    Austria Czechia Denmark Finland France Germany +5

  • A study comparing RP2 with nivolumab versus ipilimumab with nivolumab in adults with metastatic uveal melanoma not previously treated with immune checkpoint inhibitors

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Uveal melanoma
    Investigated Drugs:
    • RP2
    • Ipilimumab
    • Nivolumab
    France Germany Italy Poland Spain

  • A Study Testing the Safety of CD19-Targeted CAR T-Cell Therapy in Children and Young Adults with Relapsed or Refractory B-Cell Cancers

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia recurrent
    • B-cell lymphoma recurrent
    • B-cell lymphoma refractory
    Investigated Drugs:
    • MB-HUCART19.1
    The Netherlands

  • Study of Fecal Microbiota Transplantation Compared to Sham Treatment for Patients with Primary Sclerosing Cholangitis

    Not yet recruiting

    4 1
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    • Placebo
    France
Previous Page
1 … 746 747 748 749 750 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!